Molecular Epidemiology of Measles in California, United States-2019.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
17 09 2021
Historique:
received: 17 11 2020
accepted: 26 01 2021
pubmed: 3 2 2021
medline: 16 2 2022
entrez: 2 2 2021
Statut: ppublish

Résumé

In 2019, the United States (US) experienced the highest number of measles importations and cases in the postelimination era. More than a quarter of imported cases entered the US through California. Measles surveillance efforts in California resulted in the identification of 26 importations, 6 outbreaks, and 72 cases in 2019. Only genotype B3 and D8 measles strains were detected. Genotype-specific differences were noted in the incidence of vaccine failures, hospitalizations, and severe complications among cases. A targeted whole genome sequencing approach provided higher-resolution discrimination between epidemiologically linked and sporadically introduced strains than conventional N450 sequencing. Our report underscores the importance of ensuring appropriate measles vaccination status, especially prior to international travel to measles-endemic regions, and highlights the value of a strong measles surveillance system in minimizing outbreaks and preserving measles elimination status in the US.

Identifiants

pubmed: 33528506
pii: 6126504
doi: 10.1093/infdis/jiab059
doi:

Substances chimiques

Measles Vaccine 0
DNA-Directed RNA Polymerases EC 2.7.7.6

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1015-1023

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

William S Probert (WS)

Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, California, USA.

Rosie Glenn-Finer (R)

Immunization Branch, California Department of Public Health, Richmond, California, USA.

Alex Espinosa (A)

Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, California, USA.

Cynthia Yen (C)

Immunization Branch, California Department of Public Health, Richmond, California, USA.

Lauren Stockman (L)

Immunization Branch, California Department of Public Health, Richmond, California, USA.

Kathleen Harriman (K)

Immunization Branch, California Department of Public Health, Richmond, California, USA.

Jill K Hacker (JK)

Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, California, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH